Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZQ09
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,358
Award facts
- Contract value 100% obligated
- $17,357.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $17,357.75 by the Defense Logistics Agency (DLA) for the supply of Nexplanon 68 mg implants. This firm fixed-price delivery order, awarded on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a specific product requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The IDC, valued at $499,999,999 and valid through November 2026, operates under the SPE2DB program and authorizes the DLA to issue delivery orders for a comprehensive range of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities nationwide. No set-aside designation was utilized for this award.
Nexplanon implants are hormonal contraceptive devices widely used in military and federal healthcare systems. This delivery order exemplifies DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in Defense Logistics Agency procurement. The company's contract portfolio demonstrates consistent success in securing orders for diverse pharmaceutical products, including prescription medications, biologics, vaccines, and specialty pharmaceuticals for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FZQ09?
SPE2DB25FZQ09 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FZQ09 worth?
The government has obligated $17,358 on SPE2DB25FZQ09.
Is contract SPE2DB25FZQ09 an order under another contract?
Yes. SPE2DB25FZQ09 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZQ09 competed?
The extent of competition for SPE2DB25FZQ09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award